DOUGLAS RICHARD
Director · 4 filings · Latest: Jun 18, 2026
Aldeyra Therapeutics, Inc.
MAXCYTE, INC.
NOVAVAX INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
NVAX | DOUGLAS RICHARD | Director | Jun 20, 2026 | Option Exercise | — | 18,880 | — | 73,220 | |
ALDX | DOUGLAS RICHARD | Director | Mar 19, 2026 | Purchase | $1.40 | 70,000 | $98.0K | 195,000 | |